| Healing Hearts Counseling & Consulting, L.l.c. | |
|
1212 East Kirk Hugo OK 74743 | |
| (580) 326-5279 | |
| (580) 326-8047 |
| Full Name | Healing Hearts Counseling & Consulting, L.l.c. |
|---|---|
| Speciality | Clinic/Center |
| Location | 1212 East Kirk, Hugo, Oklahoma |
| Authorized Official Name and Position | Dana Kay Nash (CLINICAL DIRECTOR/OWNER) |
| Authorized Official Contact | 5803174194 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Healing Hearts Counseling & Consulting, L.l.c. 1212 E Kirk St Hugo OK 74743-3607 Ph: (580) 326-5279 | Healing Hearts Counseling & Consulting, L.l.c. 1212 East Kirk Hugo OK 74743 Ph: (580) 326-5279 |
| NPI Number | 1144739657 |
|---|---|
| Provider Enumeration Date | 09/27/2017 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 9335402528 |
|---|---|
| Medicare Enrollment ID | O20180423001248 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
A new supplemental issue of The Gerontologist urges aging researchers to include representative samples of ethnically diverse populations in their work. The publication also identifies research priorities for moving the science of recruitment and retention forward, in addition to providing several strategies that scholars can employ in their work.
Vinicius Novaes Rocha, a researcher at the Federal University of Juiz de Fora in Brazil, provides an insight into the role of the renin-angiotensin on the pathophysiology of COVID-19, paving the way for developing new treatment methods in the journal Medical Hypotheses.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144739657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0850X | Clinic/center - Adult Mental Health | (* (Not Available)) | Primary |
| 261QM0855X | Clinic/center - Adolescent And Children Mental Health | (* (Not Available)) | Secondary |
| Provider Name | Dana K Nash |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1114257946 PECOS PAC ID: 0749543874 Enrollment ID: I20180424000770 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
A new supplemental issue of The Gerontologist urges aging researchers to include representative samples of ethnically diverse populations in their work. The publication also identifies research priorities for moving the science of recruitment and retention forward, in addition to providing several strategies that scholars can employ in their work.
Vinicius Novaes Rocha, a researcher at the Federal University of Juiz de Fora in Brazil, provides an insight into the role of the renin-angiotensin on the pathophysiology of COVID-19, paving the way for developing new treatment methods in the journal Medical Hypotheses.
› Verified 5 days ago
| Provider Name | Angela Ashton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932408333 PECOS PAC ID: 7113337445 Enrollment ID: I20201207000369 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
A new supplemental issue of The Gerontologist urges aging researchers to include representative samples of ethnically diverse populations in their work. The publication also identifies research priorities for moving the science of recruitment and retention forward, in addition to providing several strategies that scholars can employ in their work.
Vinicius Novaes Rocha, a researcher at the Federal University of Juiz de Fora in Brazil, provides an insight into the role of the renin-angiotensin on the pathophysiology of COVID-19, paving the way for developing new treatment methods in the journal Medical Hypotheses.
› Verified 5 days ago
| Provider Name | Mary Frazier |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1497985840 PECOS PAC ID: 8921459439 Enrollment ID: I20240122004038 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
A new supplemental issue of The Gerontologist urges aging researchers to include representative samples of ethnically diverse populations in their work. The publication also identifies research priorities for moving the science of recruitment and retention forward, in addition to providing several strategies that scholars can employ in their work.
Vinicius Novaes Rocha, a researcher at the Federal University of Juiz de Fora in Brazil, provides an insight into the role of the renin-angiotensin on the pathophysiology of COVID-19, paving the way for developing new treatment methods in the journal Medical Hypotheses.
› Verified 5 days ago
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
A new supplemental issue of The Gerontologist urges aging researchers to include representative samples of ethnically diverse populations in their work. The publication also identifies research priorities for moving the science of recruitment and retention forward, in addition to providing several strategies that scholars can employ in their work.
Vinicius Novaes Rocha, a researcher at the Federal University of Juiz de Fora in Brazil, provides an insight into the role of the renin-angiotensin on the pathophysiology of COVID-19, paving the way for developing new treatment methods in the journal Medical Hypotheses.
› Verified 5 days ago
Red River Counseling Center, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 100 N 5th St, Hugo, OK 74743 Phone: 580-326-9475 Fax: 580-326-9475 | |
Healing Hearts Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 E Jackson St, Hugo, OK 74743 Phone: 580-326-7529 | |
Southern Oklahoma Treatment Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1213 East Jackson Street, Hugo, OK 74743 Phone: 580-326-7400 Fax: 580-326-6211 | |
Healing Hearts Counseling Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 E Jackson St, Hugo, OK 74743 Phone: 580-317-4194 | |
Brighter Heights Oklahoma, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2816 E Jackson St, Suite C, Hugo, OK 74743 Phone: 580-298-2830 | |
Southeastern Oklahoma Family Services, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1213 E Jackson St, Hugo, OK 74743 Phone: 580-326-7400 Fax: 580-326-6211 | |
Pathways Counseling Center Of Oklahoma Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 112 W Jackson St, Hugo, OK 74743 Phone: 580-326-9128 |